Progyny, Inc. reports developments in women's health and family building benefits, including fertility care access, employer demand, product expansion, and financial results. The company provides benefit solutions for employers, health plans, and benefit purchasers, combining concierge support, coaching, education, digital tools, and access to a network of fertility and women's health specialists.
Recurring updates include quarterly earnings, financial guidance, selling-season activity, share repurchases, investor conference appearances, and offerings such as Progyny Select, a fully insured supplemental fertility and family building plan for small U.S. employers.
Progyny, Inc. (Nasdaq: PGNY), a leader in fertility benefits management, announced participation in the Goldman Sachs 41st Annual Global Healthcare Conference on June 9, 2020. CEO David Schlanger and President Pete Anevski will join a fireside chat at 4:40 P.M. Eastern Time. Progyny aims to redefine fertility benefits, offering solutions that include dedicated Patient Care Advocates and access to a network of specialists. Recognized as a CNBC 50 Disruptor and among the fastest-growing companies, Progyny continues to innovate in family building benefits.
Progyny, Inc. (Nasdaq: PGNY) reported a 72% increase in revenue for Q1 2020, achieving $81.0 million, up from $47.2 million in Q1 2019. This growth was driven by a 47% rise in fertility services revenue. The company also reported $12.1 million in operating cash flow and net income of $4.1 million, a 61% increase year-over-year. Despite disruptions due to COVID-19, management remains optimistic about recovery and expects a minimum of $45 million in revenue for Q2 2020. However, uncertainty still exists regarding the full resumption of services amid ongoing pandemic challenges.
Progyny, a leader in fertility benefits management, announced that CEO David Schlanger and President Pete Anevski will participate in a fireside chat at the BofA Securities 2020 Health Care Conference on May 14, 2020, at 3:00 PM ET. The event will be accessible via live audiocast and replay on Progyny's investor website. Progyny aims to redefine family building benefits, providing education and access to fertility specialists, while reducing healthcare costs. The company has earned multiple accolades, including recognition from CNBC and Financial Times.